Eastbourne Capital Management News
Most Popular Eastbourne Capital Management Story
Amylin's fate awaits today's vote
Today's the big day for Amylin Pharmaceuticals and its rebel investors. Shareholders will choose between current management and a management overhaul, between company nominees to its board and Read more...
Latest Headlines
- May 28, 2009
- May 27, 2009
- May 22, 2009
- May 18, 2009
- May 6, 2009
- April 23, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
